How does comorbidity influence survival in idiopathic pulmonary fibrosis?

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias. It is a serious and progressive lung disease with a median survival of three years. The role of comorbidities in the prognosis of IPF is not clear.
Original languageEnglish
JournalRespiratory Medicine
Publication statusPublished - 2 Feb 2014

See relations at Aarhus University Citationformats

ID: 71859445